Though experts are quite sure exactly how retinol may regulate the production of sebum—an oily, waxy substance produced naturally by skin as a lubricant, one study found that certain retinoids can ...

TRex Bio, Inc. ("TRexBio"), a clinical-stage biotechnology company decoding human tissue immune biology to create revolutionary therapeutics, today announced that it has initiated dosing of healthy ...

WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has announced the initiation of a Phase 2 trial for its investigational drug bosakitug (ATI-045), targeting moderate-to-severe atopic dermatitis ...

Two dermatologists explain everything you need to know about the viral (and surprisingly potent) skincare ingredient ...

Researchers are also investigating the PD-1 immune checkpoint inhibitor as treatment before surgical and radiation treatment.

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive final results from the overall ...

Researchers have identified C5aR1 as a novel biomarker for metastasis risk and poor prognosis in patients with cutaneous ...

A recently published review explores how diet, gut dysbiosis, and probiotics may influence rosacea symptoms through immune ...

Agency supports primary and novel secondary and exploratory endpoints proposed for Phase 3 Trial(s) Opportunity to utilize ...

There is limited but promising evidence for the use of adalimumab and tofacitinib in cutaneous disease and efzofitimob in pulmonary disease. Study interpretation is limited by small sample sizes and ...

The moderate to severe atopic dermatitis market is experiencing strong growth driven by rising global prevalence and heightened awareness, fueling de ...

Fan and his colleagues deleted three different forms of the receptors (alpha, beta, and gamma) in the muscle tissues of mice and examined the resulting effects. They found that while the most ...